Table 2.
Correlation between serum PODXL level and clinicopathological parameters in PDAC
| Characteristics | Serum PODXL level (ng/mL)
|
P-value | |
|---|---|---|---|
| Median | IQR | ||
| Age, years | 0.699 | ||
| <70 (n=8) | 8.6 | 7.4–10.3 | |
| ≥70 (n=15) | 8.7 | 7.1–15.7 | |
| Gender | 0.310 | ||
| Male (n=12) | 9.3 | 7.4–15.0 | |
| Female (n=11) | 8.4 | 6.7–10.4 | |
| Diagnosed with diabetes | 0.766 | ||
| Yes (n=5) | 8.7 | 6.7–11.4 | |
| No (n=18) | 8.6 | 7.3–12.7 | |
| Diagnosed with hypertension | 0.321 | ||
| Yes (n=10) | 7.7 | 6.8–9.6 | |
| No (n=13) | 9.3 | 8.4–13.3 | |
| Serum uric acid | 0.553 | ||
| Upregulated (n=3) | 10.8 | 9.3–12.0 | |
| Normal range (n=20) | 8.6 | 6.9–11.9 | |
| Serum triglyceride | 0.785 | ||
| Upregulated (n=2) | 8.3 | 7.7–8.8 | |
| Normal range (n=21) | 8.7 | 6.9–13.3 | |
| Stagea | 0.973 | ||
| 0, I, II (n=7) | 8.5 | 7.0–18.2 | |
| III, IV (n=16) | 8.7 | 7.1–11.4 | |
| Tumor diameter | 0.137 | ||
| 0–3 cm (n=13) | 9.3 | 8.4–13.3 | |
| >3 cm (n=10) | 7.1 | 6.7–10.3 | |
Note:
a
Classified according to the classification of the International Union against Cancer.
Abbreviations: IQR, interquartile range; PDAC, pancreatic ductal adenocarcinoma; PODXL, podocalyxin.